Palisade Bio (PALI) Exchange Rate Effect (2013 - 2021)
Palisade Bio (PALI) posted quarterly Exchange Rate Effect of -$1042.0 for Q1 2021, down 50.58% year-over-year from -$2108.4 in Q1 2020, and up 65.21% quarter-over-quarter from -$2995.0 in Q4 2020.
Powered by 
Analysis
Palisade Bio (PALI) Exchange Rate Effect (2013 - 2021) Analysis & Trends
Palisade Bio (PALI) has reported Exchange Rate Effect for 9 consecutive years, with -$1042.0 the latest figure, recorded in Q1 2021.
- In Q1 2021, Exchange Rate Effect fell 50.58% year-over-year to -$1042.0; the TTM figure through Mar 2021 stood at -$1535.0 (up 79.84% YoY), while the FY2020 annual figure was -$1185.0, up 80.31% from the prior year.
- Exchange Rate Effect grew to -$1042.0 in Q1 2021 per PALI's latest filing, from -$2995.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $2639.0 in Q3 2020 and bottomed at -$6443.0 in Q3 2019.
- Historically, Exchange Rate Effect has averaged -$985.53 across 5 years, with a median of -$692.0 in 2020.
- On a YoY basis, Exchange Rate Effect climbed as much as 372.28% in 2018 and fell as far as 1320.11% in 2018.
- Palisade Bio's Exchange Rate Effect stood at $816.0 in 2017, then sank by 412.13% to -$2547.0 in 2018, then soared by 129.05% to $740.0 in 2019, then slumped by 504.73% to -$2995.0 in 2020, then soared by 65.21% to -$1042.0 in 2021.
- Business Quant data shows PALI's Exchange Rate Effect at -$1042.0 in Q1 2021, -$2995.0 in Q4 2020, and $2639.0 in Q3 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -287,000.00 |
| 10 | Palisade Bio | 440.73 Mn | 315.53 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2021 | -1,042.00 |
| Dec 31, 2020 | -2,995.00 |
| Sep 30, 2020 | 2,639.00 |
| Jun 30, 2020 | -137.00 |
| Mar 31, 2020 | -692.00 |
| Dec 31, 2019 | 740.00 |
| Sep 30, 2019 | -6,443.00 |
| Jun 30, 2019 | -1,218.00 |
| Mar 31, 2019 | 903.00 |
| Dec 31, 2018 | -2,547.00 |
| Sep 30, 2018 | -3,342.00 |
| Jun 30, 2018 | -2,542.00 |
| Mar 31, 2018 | 501.00 |
| Dec 31, 2017 | 816.00 |
| Sep 30, 2017 | -1,032.00 |
| Jun 30, 2017 | -179.00 |
| Mar 31, 2017 | -184.00 |
| Dec 31, 2016 | -1,436.00 |
| Sep 30, 2016 | 865.00 |
| Jun 30, 2016 | 751.00 |